Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

GSK cancer division delivers good news after string of R&D setbacks

Addressing leadership barriers for women in tech and pharma

Elon Musk’s Neuralink brain interface chip set for human trials

Amgen to push latecomer obesity drug into midstage testing

Sanofi, Amgen acknowledge Horizon interest as J&J steps back

TC Biopharm

Cancer attacked by T cells 600

News/ News/ Oncology/ R&D/ UK & Europe/ US

Scotland’s TC BioPharm joins bluebird to develop next-gen CAR-T

Richard Staines bluebird bio, CAR-T cancer, R&D, TC Biopharm 0 Comment

US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR-T

X

Scotland’s TC BioPharm joins bluebird to develop next-gen CAR-T

https://pharmaphorum.com/news/scotlands-tc-biopharma-joins-bluebird-develop-next-gen-car-t/

T-cells attacking cancer cell illustration of microscopic photos

News/ UK & Europe

Scottish firm gets EU funding for ‘off the shelf’ cancer cell therapy

Richard Staines Biotech, cancer, Kite Pharma, TC Biopharm 0 Comment

First patients could be treated in 2019.

X

Scottish firm gets EU funding for ‘off the shelf’ cancer cell therapy

https://pharmaphorum.com/news/tcb-funding-off-shelf-cancer-therapy/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

Sanofi, Amgen acknowledge Horizon interest as J&J steps back
Eisai's full lecanemab phase 3 trial results for Alzheimer's presented at CTAD
Elon Musk’s Neuralink brain interface chip set for human trials
Amgen to push latecomer obesity drug into midstage testing
ViiV Healthcare study reveals outdated perceptions of HIV

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com